Tekturna HCT

Type: Product
Name: Tekturna HCT
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Human medicines European public assessment report (EPAR): Rasilez HCT, aliskiren / hydrochlorothiazide, Revision: 6, Authorised

This is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach its recommendations on how to use the medicine.If you need more information ... [Published European Medicines Agency - Oct 02 2014]
First reported Jun 06 2014 - Updated Jun 06 2014 - 1 reports

GBI Research report shows key patent expiries to lead global anti-hypertensive market through fluctuating growth period by 2020

Multiple major drug patent expiries will cause the global anti-hypertensive market value to decline from $40 billion in 2013 to $37.6 billion by 2020, at a negative Compound Annual Growth Rate (CAGR) of 0.9 per cent says business intelligence provider ... [Published PharmaBiz - Jun 06 2014]
First reported Jun 03 2014 - Updated Jun 03 2014 - 1 reports

New Release on Breast Cancer Therapeutics in Major Developed Markets to 2020 by Researchmoz.us

ResearchMoz.us include new market research report "Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs" to its huge collection of research reports. "Breast Cancer ... [Published PRWeb - Jun 03 2014]

Quotes

ResearchMoz.us include new marketmarket research report "Breast Cancer Therapeutics in Major Developed Markets to 2020 - Approval of Novel Therapies to Support Continued Dominance of HER2 Targeted Drugs" to its huge collection of research reports...

More Content

All (3) | News (3) | Reports (0) | Blogs (0) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Human medicines European public assessment repo... [Published European Medicines Agency - Oct 02 2014]
GBI Research report shows key patent expiries t... [Published PharmaBiz - Jun 06 2014]
New Release on Breast Cancer Therapeutics in Ma... [Published PRWeb - Jun 03 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.